GRA Venture Fund logo

GRA Venture Fund

North America, Georgia, United States, Atlanta

Description

GRA Venture Fund, LLC is a private investment fund established in 2007, playing a pivotal role in the commercialization of cutting-edge technology emerging from Georgia's leading research universities. Based in Atlanta, Georgia, the fund's core mission is to bridge the critical gap between groundbreaking academic research and market-ready ventures. It achieves this by providing essential early-stage capital to companies that are typically participants in the Georgia Research Alliance (GRA) Ventures commercialization program, ensuring that promising innovations developed within the state's academic institutions can successfully transition into viable commercial enterprises.

The fund primarily targets Georgia-based companies that are leveraging intellectual property and discoveries originating from university research. GRA Venture Fund focuses on early-stage opportunities, including seed and early venture rounds, where its capital can have a transformative impact on nascent companies. Initial investments from the fund typically range from $250,000 to $1 million, reflecting its commitment to providing significant seed and Series A funding to help these companies achieve key milestones, such as product development, market validation, and team expansion. Beyond initial capital, the fund also has the capacity to make follow-on investments in its most promising portfolio companies, supporting their growth through subsequent funding rounds.

With a strategic alignment with the Georgia Research Alliance, GRA Venture Fund benefits from a robust pipeline of high-potential, deep-tech startups. Since its inception, the fund has demonstrated significant activity within the Georgia innovation ecosystem. It has deployed capital across multiple funds, accumulating a total of $70 million in committed capital, including a $20 million Fund I, a $25 million Fund II, and another $25 million for Fund III. This capital has been strategically deployed into over 60 companies, fostering innovation across diverse sectors such as life sciences, information technology, and advanced materials. The fund's success is further evidenced by its portfolio, which includes more than 10 successful exits, underscoring its ability to identify and nurture companies that deliver tangible returns and contribute to the state's economic development.

This structure allows GRA Venture Fund to serve as a cornerstone investor for university spin-outs and startups, providing not just financial backing but also strategic guidance through its experienced management team and advisory board. Its focused approach ensures that Georgia's intellectual capital is effectively translated into economic prosperity, solidifying its position as a key player in the regional venture capital landscape.

Investor Profile

GRA Venture Fund has backed more than 23 startups, with 0 new investments in the last 12 months alone. The firm has led 7 rounds, about 30% of its total and boasts 5 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series A, Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Health Care, Biotechnology, Software.
  • Typical check size: $250K – $1M.

Stage Focus

  • Seed (39%)
  • Series A (26%)
  • Series B (13%)
  • Series Unknown (9%)
  • Series D (9%)
  • Series C (4%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Biotechnology
  • Software
  • Medical
  • Fraud Detection
  • Biopharma
  • Therapeutics
  • Medical Device
  • Saas
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does GRA Venture Fund frequently co-invest with?

Brewer Lane Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 2
Hatteras Venture Partners
North America, North Carolina, United States, Durham
Co-Investments: 2
Domain Associates
North America, California, United States, San Diego
Co-Investments: 2
Spider Capital
North America, California, United States, San Francisco
Co-Investments: 3
Imlay Investments
North America, Georgia, United States, Atlanta
Co-Investments: 2
TechSquare Labs
North America, Georgia, United States, Atlanta
Co-Investments: 4
Lumira Ventures
North America, Ontario, Canada, Toronto
Co-Investments: 2
Sigma Partners
North America, Massachusetts, United States, Boston
Co-Investments: 2
Dynamk Capital
North America, New York, United States, New York
Co-Investments: 2
Palomar Ventures
North America, California, United States, Ladera Ranch
Co-Investments: 2

Which angels does GRA Venture Fund often collaborate with?

KL
North America, New York, United States, New York
Shared Deals: 1
KD
North America, California, United States, San Francisco
Shared Deals: 1
MW
North America, Georgia, United States, Atlanta
Shared Deals: 1
BL
North America, California, United States, Menlo Park
Shared Deals: 1
CB
North America, California, United States, San Francisco
Shared Deals: 1
MB
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by GRA Venture Fund?

Lucid Scientific

Atlanta, Georgia, United States

Lucid Scientific is a biotechnology company that designs and develops a series of real-time cellular activity monitors.

BiotechnologyMedicalProduct Research
Series ASep 5, 2023
Amount Raised: $7,000,000
Micron Biomedical

Atlanta, Georgia, United States

Micron Biomedical is a clinical-stage biopharmaceutical company on a rapid path to bring drugs and vaccines to market.

BiopharmaBiotechnologyHealth CareWellness
Series ANov 25, 2022
Amount Raised: $14,000,000
BioCircuit Technologies

Atlanta, Georgia, United States

BioCircuit Technologies develops noninvasive electrophysiology devices which monitor, control, and repair peripheral nerves.

BiotechnologyHealth CareManufacturingMedicalMedical Device
SeedSep 27, 2022
Amount Raised: $9,000,000
Codoxo

Duluth, Georgia, United States

Codoxo is an AI-assisted platform for the healthcare sector.

AnalyticsArtificial Intelligence (AI)Fraud DetectionHealth CareHealth InsuranceInsurTechMachine LearningSoftware
Series BFeb 3, 2022
Amount Raised: $5,249,992
Antios Therapeutics

Atlanta, Georgia, United States

Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.

BiopharmaBiotechnologyTherapeutics
Series BNov 3, 2021
Amount Raised: $75,000,000
Lucid Scientific

Atlanta, Georgia, United States

Lucid Scientific is a biotechnology company that designs and develops a series of real-time cellular activity monitors.

BiotechnologyMedicalProduct Research
SeedOct 1, 2020
Amount Raised: $3,000,000
Codoxo

Duluth, Georgia, United States

Codoxo is an AI-assisted platform for the healthcare sector.

AnalyticsArtificial Intelligence (AI)Fraud DetectionHealth CareHealth InsuranceInsurTechMachine LearningSoftware
Series AJul 2, 2020
Amount Raised: $7,000,000
Acivilate

Atlanta, Georgia, United States

Acivilate is a provider of Software-as-a-Service (SaaS) company committed to reducing recidivism.

CRMEnterpriseHealth CareInformation ServicesInformation TechnologySaaSSoftware
SeedDec 11, 2017
Amount Raised: $3,000,000
Carbice Corporation

Atlanta, Georgia, United States

Carbice is developing a product used to dissipate heat away from product packaging to stop electronic devices from overheating.

Energy ManagementIndustrial DesignIndustrial EngineeringSemiconductor
SeedJul 19, 2017
Amount Raised: $1,500,000
Codoxo

Duluth, Georgia, United States

Codoxo is an AI-assisted platform for the healthcare sector.

AnalyticsArtificial Intelligence (AI)Fraud DetectionHealth CareHealth InsuranceInsurTechMachine LearningSoftware
SeedJun 15, 2017
Amount Raised: $1,500,000